Medical Properties Trust
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Medical Properties Trust generated cash of $505,786,000, which is less than the previous year. Cash used in financing activities reached the amount of -$1,020,327,000 last year. Net change in cash is therefore $14,414,000.
Cash Flow
| 2014 | 150.44M | -850.02M | 802.56M |
|---|---|---|---|
| 2015 | 206.99M | -1.94B | 1.80B |
| 2016 | 264.68M | -926.54M | 552.56M |
| 2017 | 363.10M | -2.36B | 2.07B |
| 2018 | 449.08M | 564.17M | -345.87M |
| 2019 | 494.11M | -4.88B | 5.04B |
| 2020 | 617.63M | -2.94B | 1.40B |
| 2021 | 811.65M | -3.85B | 2.94B |
| 2022 | 739.01M | 396.05M | -1.34B |
| 2023 | 505.78M | 517.55M | -1.02B |
MPW Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 241.53M | 461.88M | 556.36M | 1.46B | 822.42M | 172.24M | 83.24M | 195.54M | 144.54M | 45.97M |
Operating activities | ||||||||||
Net income | -558.12M | 903.81M | 656.94M | 432.27M | 376.40M | 1.01B | 291.23M | 225.93M | 139.92M | 50.79M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 616.12M | 345.57M | 333.78M | 275.95M | 156.57M | 141.49M | 131.97M | 97.60M | 71.82M | 55.16M |
Stock-based compensation expense | 33.25M | 49.42M | 52.11M | 47.15M | 32.18M | 16.50M | 9.94M | 7.94M | 11.12M | 9.16M |
| Deferred income tax benefit | 33.25M | 49.42M | 52.11M | 47.15M | 32.18M | 16.50M | 9.94M | 7.94M | 11.12M | 9.16M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -116.42M | -23.86M | -2.43M | 12.90M | 46.49M | -21.11M | -13.24M | -5.59M | -3.85M |
Inventories | 0 | 116.42M | 23.86M | 2.43M | -39.63M | 5.59M | -4.45M | -18.35M | -8.29M | 764K |
Accounts payable | -4.59M | 33.57M | 54.05M | -18.42M | 39.63M | -5.59M | 2.49M | 41.58M | 26.54M | 6.20M |
Cash generated by operating activities | 505.78M | 739.01M | 811.65M | 617.63M | 494.11M | 449.08M | 363.10M | 264.68M | 206.99M | 150.44M |
Investing activities | ||||||||||
Purchases Of Investments | -294.16M | -207.39M | -289.23M | -36.18M | -293.16M | -138.44M | -94.97M | -119.42M | -17.33M | -13.12M |
Investments In Property Plant And Equipment | 0 | -1.54B | -65.54M | -4.28B | -4.85B | -1.43B | -2.24B | 27.55M | -2.21B | 0 |
Acquisitions Net | -235.18M | -1.31B | -5.28B | -4.17B | -4.56B | -1.43B | -2.24B | -1.68B | -2.21B | -767.69M |
Cash generated by investing activities | 517.55M | 396.05M | -3.85B | -2.94B | -4.88B | 564.17M | -2.36B | -926.54M | -1.94B | -850.02M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 1.05B | 411.10M | 2.53B | 94.23M | 547.78M | 0 | 817.38M | 138.17M |
Payments for dividends | -615.39M | -698.53M | -643.47M | -567.96M | -411.69M | -363.90M | -326.72M | -218.39M | -182.98M | -144.36M |
Repurchases of common stock | -8.07M | -17.94M | 3.96B | 2.37B | 0 | 759.73M | 0 | 0 | 0 | 915.62M |
Repayments of term debt | -420.25M | -537.49M | -1.39B | -800M | 2.98B | -811.71M | 1.86B | -385.29M | 1.19B | -100.26M |
Cash used in financing activities | -1.02B | -1.34B | 2.94B | 1.40B | 5.04B | -345.87M | 2.07B | 552.56M | 1.80B | 802.56M |
Net Change In Cash | 14.41M | -220.34M | -94.48M | -911.62M | 645.56M | 650.17M | 88.23M | -112.30M | 51M | 98.56M |
Cash at end of period | 255.95M | 241.53M | 461.88M | 556.36M | 1.46B | 822.42M | 171.47M | 83.24M | 195.54M | 144.54M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |